![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
G Schulteis, A Markou, LH Gold, L Stinus and GF Koob
Department of Neuropharmacology, Scripps Research Institute, La Jolla, California.
In addition to classic somatic signs of opiate withdrawal, a number of behavioral measures are known to be sensitive, reliable indices of naloxone-precipitated opiate withdrawal in rats. It has been suggested that some behavioral indices of withdrawal may be more sensitive to precipitation by naloxone than some somatic signs of withdrawal. The purpose of the present study was to permit a quantitative assessment of the relative sensitivity to naloxone of a variety of behavioral and somatic indices of opiate withdrawal. Male Wistar rats were implanted s.c. with either two morphine (each 75 mg of base) or two placebo pellets. No sooner than 3 days after implantation, naloxone dose- response functions were determined with several behavioral paradigms and ratings of a variety of somatic withdrawal signs. In dependent rats, very low (0.004 or 0.01 mg/kg) doses of naloxone produced the following behavioral effects: 1) a reduction in spontaneous locomotor activity, 2) a disruption of schedule-controlled (fixed ratio 15) operant responding for food, 3) an elevation in intracranial self- stimulation thresholds and 4) a conditioned place aversion. These same doses of naloxone produced no significant effects in nondependent (placebo pellet-implanted) rats. The ED50 values for naloxone precipitation of all behavioral signs of withdrawal were below 0.013 mg/kg; the ED50 values for naloxone precipitation of most somatic withdrawal signs were higher. The behavioral measures used in these studies therefore represent highly sensitive indices of opiate withdrawal.
This article has been cited by other articles:
|
|
 |
|
  E. Knapska, K. Radwanska, T. Werka, and L. Kaczmarek Functional Internal Complexity of Amygdala: Focus on Gene Activity Mapping After Behavioral Training and Drugs of Abuse Physiol Rev, October 1, 2007; 87(4): 1113 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Chartoff, S. D. Mague, M. F. Barhight, A. M. Smith, and W. A. Carlezon Jr Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J. Neurosci., June 14, 2006; 26(24): 6450 - 6457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Kenny, S. A. Chen, O. Kitamura, A. Markou, and G. F. Koob Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J. Neurosci., May 31, 2006; 26(22): 5894 - 5900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cavun, G. Goktalay, and W. R. Millington Glycyl-Glutamine, an Endogenous {beta}-Endorphin-Derived Peptide, Inhibits Morphine-Induced Conditioned Place Preference, Tolerance, Dependence, and Withdrawal J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 949 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Ahmed, R. Lutjens, L. D. van der Stap, D. Lekic, V. Romano-Spica, M. Morales, G. F. Koob, V. Repunte-Canonigo, and P. P. Sanna Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction PNAS, August 9, 2005; 102(32): 11533 - 11538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Kenny and A. Markou Conditioned Nicotine Withdrawal Profoundly Decreases the Activity of Brain Reward Systems J. Neurosci., June 29, 2005; 25(26): 6208 - 6212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Frenois, L. Stinus, F. Di Blasi, M. Cador, and C. Le Moine A Specific Limbic Circuit Underlies Opiate Withdrawal Memories J. Neurosci., February 9, 2005; 25(6): 1366 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Holtzman Discrimination of a Single Dose of Morphine Followed by Naltrexone: Substitution of Other Agonists for Morphine and Other Antagonists for Naltrexone in a Rat Model of Acute Dependence J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1033 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Druhan, C. L. Walters, and G. Aston-Jones Behavioral Activation Induced by D2-Like Receptor Stimulation during Opiate Withdrawal J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 531 - 538. [Abstract] [Full Text]
|
|
|
|
|
|
S. S. Watkins, L. Stinus, G. F. Koob, and A. Markou Reward and Somatic Changes during Precipitated Nicotine Withdrawal in Rats: Centrally and Peripherally Mediated Effects J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1053 - 1064. [Abstract] [Full Text]
|
|
|
|
|
|
S. Caillé, E. F. Espejo, J.-P. Reneric, M. Cador, G. F. Koob, and L. Stinus Total Neurochemical Lesion of Noradrenergic Neurons of the Locus Ceruleus Does Not Alter Either Naloxone-Precipitated or Spontaneous Opiate Withdrawal nor Does It Influence Ability of Clonidine To Reverse Opiate Withdrawal J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 881 - 892. [Abstract] [Full Text]
|
|
|
|
|
|
K. W. Easterling and S. G. Holtzman Discriminative Stimulus Effects of Naltrexone After a Single Dose of Morphine in the Rat J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1269 - 1277. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. F. Koob, M. Rocio, A. Carrera, L. H. Gold, C. J. Heyser, C. Maldonado-Irizarry, A. Markou, L. H. Parsons, A. J. Roberts, G. Schulteis, et al. Substance dependence as a compulsive behavior J Psychopharmacol, January 1, 1998; 12(1): 39 - 48. [Abstract] [PDF]
|
|
|
|
 |
|
 G. F. Koob and M. L. Moal Drug Abuse: Hedonic Homeostatic Dysregulation Science, October 3, 1997; 278(5335): 52 - 58. [Abstract] [Full Text]
|
|
|
|
|
|
K. W. Easterling and S. G. Holtzman Intracranial Self-Stimulation in Rats: Sensitization to an Opioid Antagonist Following Acute or Chronic Treatment with Mu Opioid Agonists, J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 188 - 199. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
